|
1
|
Gu X, Sun G, Zheng R, Zhang S, Zeng H, Sun
K, Wang S, Chen R and Wei W: Incidence and mortality of cervical
cancer in China in 2015. J Natl Cancer Cent. 2:70–77. 2022.
View Article : Google Scholar
|
|
2
|
Balasubramaniam SD, Balakrishnan V, Oon CE
and Kaur G: Key molecular events in cervical cancer development.
Medicina (Kaunas). 55:3842019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barquet-Muñoz SA, Rendón-Pereira GJ,
Acuña-González D, Peñate MV, Herrera-Montalvo LA, Gallardo-Alvarado
LN, Cantú-de León DF and Pareja R: Role of pelvic and para-aortic
lymphadenectomy in abandoned radical hysterectomy in cervical
cancer. World J Surg Oncol. 15:232017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bansal S, Lewin SN, Burke WM, Deutsch I,
Sun X, Herzog TJ and Wright JD: Sarcoma of the cervix: Natural
history and outcomes. Gynecol Oncol. 118:134–138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang L, Liu S, Li S, Chen Y, Xie B and
Zhou J: Induction mechanism of ferroptosis, necroptosis, and
pyroptosis: A novel therapeutic target in nervous system diseases.
Int J Mol Sci. 24:101272023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng X, Chen W, Gong F, Chen Y and Chen
E: The role and mechanism of pyroptosis and potential therapeutic
targets in sepsis: A review. Front Immunol. 12:7119392021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaczanowski S: Apoptosis: Its origin,
history, maintenance and the medical implications for cancer and
aging. Phys Biol. 13:0310012016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun L, Ma W, Gao W, Xing Y, Chen L, Xia Z,
Zhang Z and Dai Z: Propofol directly induces caspase-1-dependent
macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell
Death Dis. 10:5422019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen HH, Yang YX, Meng X, Luo XY, Li XM,
Shuai ZW, Ye DQ and Pan HF: NLRP3: A promising therapeutic target
for autoimmune diseases. Autoimmun Rev. 17:694–702. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kovacs SB and Miao EA: Gasdermins:
Effectors of pyroptosis. Trends Cell Biol. 27:673–684. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xue Y, Enosi Tuipulotu D, Tan WH, Kay C
and Man SM: Emerging activators and regulators of inflammasomes and
pyroptosis. Trends Immunol. 40:1035–1052. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Varghese GP, Folkersen L, Strawbridge RJ,
Halvorsen B, Yndestad A, Ranheim T, Krohg-Sørensen K, Skjelland M,
Espevik T, Aukrust P, et al: NLRP3 inflammasome expression and
activation in human atherosclerosis. J Am Heart Assoc.
5:e0030312016. View Article : Google Scholar
|
|
13
|
Wang Y, Yin B, Li D, Wang G, Han X and Sun
X: GSDME mediates caspase-3-dependent pyroptosis in gastric cancer.
Biochem Biophys Res Commun. 495:1418–1425. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang
Y, Yu T, Wu X, Shi Y, Ma P and Shu Y: Pyroptosis: A new frontier in
cancer. Biomed Pharmacother. 121:1095952020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiao L, Wu X, Zhang J, Liu L, Sui X, Zhang
R, Liu W, Shen F, Sun Y and Xi X: α-NETA induces pyroptosis of
epithelial ovarian cancer cells through the GSDMD/caspase-4
pathway. FASEB J. 33:12760–12767. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Webb K, Prakash V, Kirresh O and Stewart
A: A case of aortitis during cisplatin-based chemotherapy for
cervical cancer. BJR Case Rep. 5:201800542018.PubMed/NCBI
|
|
17
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang
Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA
MALAT1 suppresses breast cancer metastasis. Nat Genet.
50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu Y, Zhang X, Hu X, Zhou W, Zhang P,
Zhang J, Yang S and Liu Y: The effects of lncRNA MALAT1 on
proliferation, invasion and migration in colorectal cancer through
regulating SOX9. Mol Med. 24:522018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin Y, Feng SJ, Qiu S, Shao N and Zheng
JH: LncRNA MALAT1 promotes proliferation and metastasis in
epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med
Pharmacol Sci. 21:3176–3184. 2017.PubMed/NCBI
|
|
22
|
Lin N, Yao Z, Xu M, Chen J, Lu Y, Yuan L,
Zhou S, Zou X and Xu R: Long noncoding RNA MALAT1 potentiates
growth and inhibits senescence by antagonizing ABI3BP in
gallbladder cancer cells. J Exp Clin Cancer Res. 38:2442019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Q, Meng WY, Jie Y and Zhao H: LncRNA
MALAT1 induces colon cancer development by regulating
miR-129-5p/HMGB1 axis. J Cell Physiol. 233:6750–6757. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng C, Zhao Y, Li Y, Zhang T, Ma Y and
Liu Y: LncRNA MALAT1 promotes lung cancer proliferation and
gefitinib resistance by acting as a miR-200a sponge. Arch
Bronconeumol (Engl Ed). 55:627–633. 2019.(In English, Spanish).
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi B, Wang Y and Yin F:
MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT
in nasopharyngeal carcinoma cells. Cancer Biol Ther. 18:792–800.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Jiang T, Liang X, Shu S, Xiang X,
Zhang W, Guo T, Xie W, Deng W and Tang X: lncRNA MALAT1 mediated
high glucose-induced HK-2 cell epithelial-to-mesenchymal transition
and injury. J Physiol Biochem. 75:443–452. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu C, Zhuo H, Ye MY, Huang GX, Fan M and
Huang XZ: LncRNA MALAT1 promoted high glucose-induced pyroptosis of
renal tubular epithelial cell by sponging miR-30c targeting for
NLRP3. Kaohsiung J Med Sci. 36:682–691. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Broutier L, Mastrogiovanni G, Verstegen
MM, Francies HE, Gavarró LM, Bradshaw CR, Allen GE, Arnes-Benito R,
Sidorova O, Gaspersz MP, et al: Human primary liver cancer-derived
organoid cultures for disease modeling and drug screening. Nat Med.
23:1424–1435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qiu Z, He Y, Ming H, Lei S, Leng Y and Xia
ZY: Lipopolysaccharide (LPS) aggravates high glucose- and
hypoxia/reoxygenation-induced injury through activating
ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2
cardiomyocytes. J Diabetes Res. 2019:81518362019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kong M, Yao Y and Zhang H: Antitumor
activity of enzymatically hydrolyzed Ganoderma lucidum
polysaccharide on U14 cervical carcinoma-bearing mice. Int J
Immunopathol Pharmacol. 33:20587384198694892019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang T, Li Y, Zhu R, Song P, Wei Y, Liang
T and Xu G: Transcription factor p53 suppresses tumor growth by
prompting pyroptosis in non-small-cell lung cancer. Oxid Med Cell
Longev. 2019:87468952019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
So D, Shin HW, Kim J, Lee M, Myeong J,
Chun YS and Park JW: Cervical cancer is addicted to SIRT1 disarming
the AIM2 antiviral defense. Oncogene. 37:5191–5204. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rerucha CM, Caro RJ and Wheeler VL:
Cervical cancer screening. Am Fam Physician. 97:441–448.
2018.PubMed/NCBI
|
|
34
|
Prince S: Cervical cancer treatments:
Current challenges and future points of view. J Mol Oncol Res.
6:1252022.
|
|
35
|
PDQ Adult Treatment Editorial Board, .
Financial toxicity and cancer treatment (PDQ®): Health
professional version. 2022 Sep 20. PDQ Cancer Information Summaries
[Internet]. National Cancer Institute; Bethesda, MD: 2002
|
|
36
|
Chao X, Song X, Wu H, You Y, Wu M and Li
L: Selection of treatment regimens for recurrent cervical cancer.
Front Oncol. 11:6184852021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin L, Li Q, Hao W, Zhang Y, Zhao L and
Han W: Upregulation of LncRNA Malat1 induced proliferation and
migration of airway smooth muscle cells via miR-150-eIF4E/Akt
signaling. Front Physiol. 10:13372019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cooper DR, Wang C, Patel R, Trujillo A,
Patel NA, Prather J, Gould LJ and Wu MH: Human adipose-derived stem
cell conditioned media and exosomes containing MALAT1 promote human
dermal fibroblast migration and ischemic wound healing. Adv Wound
Care (New Rochelle). 7:299–308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liao K, Lin Y, Gao W, Xiao Z, Medina R,
Dmitriev P, Cui J, Zhuang Z, Zhao X, Qiu Y, et al: Blocking lncRNA
MALAT1/miR-199a/ZHX1 axis inhibits glioblastoma proliferation and
progression. Mol Ther Nucleic Acids. 18:388–399. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu J, Xu L and Zhan X: LncRNA MALAT1
regulates diabetic cardiac fibroblasts through the Hippo-YAP
signaling pathway. Biochem Cell Biol. 98:537–547. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen P, Huang Y, Wang Y, Li S, Chu H and
Rong M: MALAT1 overexpression promotes the proliferation of human
periodontal ligament stem cells by upregulating fibroblast growth
factor 2. Exp Ther Med. 18:1627–1632. 2019.PubMed/NCBI
|
|
42
|
Li GQ, Fang YX, Liu Y, Meng FR, Wu X,
Zhang CW, Zhang Y, Liu D and Gao B: MALAT1-driven inhibition of wnt
signal impedes proliferation and inflammation in fibroblast-like
synoviocytes through CTNNB1 promoter methylation in rheumatoid
arthritis. Hum Gene Ther. 30:1008–1022. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Y, Wang F, Chen G, He R and Yang L:
LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3
axis. Cell Biosci. 9:542019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hao T, Wang Z, Yang J, Zhang Y, Shang Y
and Sun J: MALAT1 knockdown inhibits prostate cancer progression by
regulating miR-140/BIRC6 axis. Biomed Pharmacother. 123:1096662020.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu N, Chen L, Wang C and Zhao H: MALAT1
knockdown inhibits proliferation and enhances cytarabine
chemosensitivity by upregulating miR-96 in acute myeloid leukemia
cells. Biomed Pharmacother. 112:1087202019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu A, Sun W and Mou F: lncRNA-MALAT1
promotes high glucose-induced H9C2 cardiomyocyte pyroptosis by
downregulating miR-141-3p expression. Mol Med Rep. 23:2592021.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zuo Y, Chen L, He X, Ye Z, Li L, Liu Z and
Zhou S: Atorvastatin regulates MALAT1/miR-200c/NRF2 activity to
protect against podocyte pyroptosis induced by high glucose.
Diabetes Metab Syndr Obes. 14:1631–1645. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Song Y, Yang L, Guo R, Lu N, Shi Y and
Wang X: Long noncoding RNA MALAT1 promotes high glucose-induced
human endothelial cells pyroptosis by affecting NLRP3 expression
through competitively binding miR-22. Biochem Biophys Res Commun.
509:359–366. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ruan J, Wang S and Wang J: Mechanism and
regulation of pyroptosis-mediated in cancer cell death. Chem Biol
Interact. 323:1090522020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou CB and Fang JY: The role of
pyroptosis in gastrointestinal cancer and immune responses to
intestinal microbial infection. Biochim Biophys Acta Rev Cancer.
1872:1–10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li J, Yang C, Li Y, Chen A, Li L and You
Z: LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome
formation. Biosci Rep. 38:BSR201711502018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu J, Yao L, Zhang M, Jiang J, Yang M and
Wang Y: Downregulation of LncRNA-XIST inhibited development of
non-small cell lung cancer by activating miR-335/SOD2/ROS signal
pathway mediated pyroptotic cell death. Aging (Albany NY).
11:7830–7846. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ren N, Jiang T, Wang C, Xie S, Xing Y,
Piao D, Zhang T and Zhu Y: LncRNA ADAMTS9-AS2 inhibits gastric
cancer (GC) development and sensitizes chemoresistant GC cells to
cisplatin by regulating miR-223-3p/NLRP3 axis. Aging (Albany NY).
12:11025–11041. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen H, Lin X, Yi X, Liu X, Yu R, Fan W,
Ling Y, Liu Y and Xie W: SIRT1-mediated p53 deacetylation inhibits
ferroptosis and alleviates heat stress-induced lung epithelial
cells injury. Int J Hyperthermia. 39:977–986. 2022. View Article : Google Scholar : PubMed/NCBI
|
